Suppliers / Naari Pte

Naari Pte

Singapore 3 duplicate records merged Updated 9 July 2026

Naari Pte is an API manufacturer based in Singapore. It holds 3 active US drug master files across a filed portfolio of 2 molecules. Its filings concentrate with US FDA, EFDA (ET) and RAMA (GE). Its GMP standing is certified by HSA (SG).

3
active US DMFs
0
valid CEPs
0
registered plants
20
filings across 5 regulators

What they file, and where

Molecule Regulators Docs
Norethisterone US FDA 2
Mifepristone US FDA 1

Also appears on these molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 9 None
EFDA (ET) 6 None
RAMA (GE) 3 None
HSA (SG) 1 2
ZAMRA (ZM) 1 None

Questions about Naari Pte

Does Naari Pte hold a US DMF or a CEP?
Naari Pte holds 3 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Naari Pte make?
2 molecules are on record against Naari Pte, including Norethisterone and Mifepristone. Each links through to that molecule's full manufacturer list.
Which regulators recognise Naari Pte's GMP?
Current GMP certificates are on record from HSA (SG). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Naari Pte comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates